临床试验
食管癌
免疫疗法
医学
癌症
外科
肿瘤科
胃肠病学
内科学
标识
DOI:10.1038/d41591-021-00022-8
摘要
Anti-PD-1 after surgery improves the survival of patients with esophageal cancers in a clinical trial. Anti-PD-1 after surgery improves the survival of patients with esophageal cancers in a clinical trial.
科研通智能强力驱动
Strongly Powered by AbleSci AI